tiprankstipranks
Trending News
More News >
Immuneering (IMRX)
NASDAQ:IMRX
US Market

Immuneering (IMRX) Revenue

Compare
346 Followers

Immuneering Revenue

Immuneering had a revenue of 0.00 in the quarter ending Mar 31, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 726.33K, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Immuneering had annual revenue of 0.00 with ― growth.
Revenue (ttm)
726.33K
Revenue Growth
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
54
Market Cap
$56.50M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
0.00
Dec 31, 2023
0.00-316.95K-100.00%
Dec 31, 2022
316.95K-1.76M-84.76%
Dec 31, 2021
2.08M-231.57K-10.02%
Dec 31, 2020
2.31M391.83K+20.41%
Dec 31, 2019
1.92M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis